Compare ETR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETR | IDXX |
|---|---|---|
| Founded | 1949 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9B | 43.6B |
| IPO Year | 2005 | 1996 |
| Metric | ETR | IDXX |
|---|---|---|
| Price | $113.81 | $541.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 9 |
| Target Price | $115.25 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 3.2M | 576.1K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | ★ 59.59 | 22.59 |
| EPS | 0.83 | ★ 3.47 |
| Revenue | ★ $12,946,686,000.00 | $4,303,702,000.00 |
| Revenue This Year | $8.40 | $10.88 |
| Revenue Next Year | $8.09 | $8.59 |
| P/E Ratio | ★ $135.18 | $157.27 |
| Revenue Growth | 8.98 | ★ 10.42 |
| 52 Week Low | $80.11 | $507.55 |
| 52 Week High | $118.45 | $769.98 |
| Indicator | ETR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 42.69 |
| Support Level | $108.95 | $523.38 |
| Resistance Level | $118.13 | $587.04 |
| Average True Range (ATR) | 2.28 | 15.84 |
| MACD | 0.48 | -1.90 |
| Stochastic Oscillator | 95.79 | 4.72 |
Entergy is a holding company with five regulated vertically integrated utilities that generate and distribute electricity to 3 million customers in Arkansas, Louisiana, Mississippi, and Texas. It is one of the largest power producers in the country with 27 gigawatts of rate-regulated owned and leased power generation capacity. Entergy was the second-largest nuclear owner in the US before it began retiring and selling its plants in the Northeast in 2014. It sold its two small gas utilities in Louisiana in 2025.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.